Transduction of antinatriuretic signals in renal proximal tubular cells in cirrhosis: Introduction to novel approaches to the treatment of sodium retention

Journal of Hepatology

Volumn 28, Issue 6, 1998, Pages 1064-1069

  Moreau, Richard ^a   Lebrec, Didier ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; NORADRENALIN; SODIUM ION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASCITES; KIDNEY PROXIMAL TUBULE; LIVER CIRRHOSIS; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SODIUM ABSORPTION; SODIUM RETENTION;

EID: 0032103896     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80358-9     Document Type: Review

References (43)

1. Skorecki KL, Brenner BM. Body fluid homeostasis on congestive heart failure and cirrhosis with ascites. Am J Med. 72:1982;323-338.
2. Wong F, Blendis LM. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor. Semin Liver Dis. 14:1994;59-70.
3. Salerno F, Badalamenti S, Incerti P, Capozza L, Mainardi L. Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis. Hepatology. 21-26:1988.
4. Laffi G, Pinzani M, Meacci E, La Villa G, Renzi D, Baldi E, et al. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. Gastroenterology. 96:1989;167-177.
5. Gines P, Tito L, Arroyo V, Llach J, Salmeron JM, Gines A, et al. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Gastroenterology. 102:1992;280-286.
6. Morali GA, Tobe SW, Skorecki KL, Blendis LM. Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol. Hepatology. 16:1992;42-48.
7. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 23:1996;164-176.
8. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-Lopez F, Rodes J. Renin, aldosterone and renal hemodynamics in cirrhosis with ascites. Eur J Clin Invest. 9:1979;69-73.
9. Bichet DG, Van Putten VJ, Schrier RW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med. 307:1982;1552-1557.
10. Henriksen JH, Christensen NJ, Ring-Larsen H. Continuous infusion of tracer norepinephrine may miscalculate unidirectional nerve uptake of norepinephrine in humans. Circ Res. 65:1989;388-395.
11. DiBona GF. Renal neural activity in hepatorenal syndrome. Kidney Int. 25:1984;841-853.
12. Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension. 15:1990;451-458.
13. Ichikawa I, Harris RC. Angiotensin actions in the kidney renewed insight into the old hormone. Kidney Int. 40:1991;583-596.
14. Carg LC. Actions of adrenergic and cholinergic drugs in renal tubular cells. Pharmacol Rev. 44:1992;81-102.
15. Bertorello AM, Katz AI. Short-term regulation of renal NaK-ATPase activity: physiological relevance and cellular mechanisms. Am J Physiol. 265:1993;F743-F755.
16. +-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol. 269:1995;C295-C311.
17. + exchanger isoforms 1 an 3 in kidney proximal tubules of hypertensive rats. Annu Rev Physiol. 55:1993;289-304.
18. + exchanger isoforms 1 and 3 in kidney proximal tubules of hypertensive rats. Circ Res. 80:1997;853-860.
19. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J. 8:1994;436-439.
20. +-ATPase. Am J Physiol. 269:1995;F673-F680.
21. Clapham DE. Calcium signaling. Cell. 80:1995;259-268.
22. +-ATPase activity in renal tubule cells. Proc Natl Acad Sci USA. 89:1992;7394-7397.
23. +-ATPase in renal tubule cells. Proc Natl Acad Sci USA. 86:1989;8068-8072.
24. Bourne HR. Pieces of the true grail: a G protien finds its target. Science. 278:1997;1898-1899.
25. Roczniak A, Burns KD. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol. 270:1996;F106-F115.
26. + transport by a cGMP-mediated mechanism in the kidney proximal tubule. Am J Physiol. 272:1997;F242-F248.
27. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol. 272:1997;F561-F568.
28. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med. 334:1996;1649-1654.
29. Girgrah N, Liu P, Blendis L, Wong F. The effect of losartan an angiotensin II receptor antagonist, on systemic and renal hemodynamics and sodium homeostasis in cirrhosis [abstract]. Hepatology. 26:1997;286. (Pt. 2).
30. Umemori H, Inoue T, Kume S, Sekiyama N, Nagao M, Itoh H, et al. Activation of the G protein Gq/11 through tyrosine phosphorylation of the α subunit. Science. 276:1997;1878-1881.
31. Berman DM, Wilkie TM, Gilman AG. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein α subunits. Cell. 86:1996;445-452.
32. Liu M, Simon MI. Regulation by cAMP-dependent protein kinase of a G-protein-mediated phospholipase C. Nature. 382:1996;83-87.
33. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J. 7:1993;328-338.
34. Felder RA, Felder CC, Eisner GM, Jose PA. The dopamine receptor in adult and maturing kidney. Am J Physiol. 257:1989;F315-F327.
35. Muff R, Fischer JA. Parathyroid hormone receptors in control of proximal tubule function. Annu Rev Physiol. 54:1992;67-79.
36. 1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study. Hepatology. 13:1991;111-116.
37. Conti M, Jin SLC, Monaco L, Repaske DR, Swinnen JV. Hormonal regulation of cyclic nucleotide phosphodiesterases. Endocr Rev. 12:1991;218-234.
38. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 39:1987;163-196.
39. Chinkers M, Garbers DL. Signal transduction by guanylyl cyclases. Annu Rev Biochem. 60:1991;553-575.
40. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 70:1990;665-699.
41. Gerbes AL. The role of atrial natriuretic peptide (ANP) in chronic liver disease. Pharmacol Ther. 58:1993;381-390.
42. Moncada S, Palmer RJM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:1991;109-142.
43. Angeli P, Bortoluzzi A, Con P, Volpin R, Camariero V, Craighero R, et al. Renal effects of zaprinast, a cyclic guanosine monophosphate (cGMP) phosphodiensterase inhibitor, in cirrhotic rats with ascites. J Hepatol. 25:1996;72. (Prt. 1).